Cancer News and Research

Latest Cancer News and Research

Scientists identify genetic factors that influence height in individuals

An international collaboration of scientists has identified a fifth of the genetic factors that cause height to vary between individuals.

6 Oct 2014

SynGen announces securement of additional financing from San Francisco-based life sciences venture capital firm

SynGen, Inc., a company that focuses on the development and commercialization of instrument systems that harvest stem and progenitor cells from umbilical cord blood, bone marrow, peripheral blood, and cell culture, announced today that it has secured additional financing from Bay City Capital, LLC, a San Francisco-based life sciences venture capital firm.

6 Oct 2014

New research on barcoding tool that tracks origin of blood cells challenges scientific dogma

A 7-year-project to develop a barcoding and tracking system for tissue stem cells has revealed previously unrecognized features of normal blood production: New data from Harvard Stem Cell Institute scientists at Boston Children's Hospital suggests, surprisingly, that the billions of blood cells that we produce each day are made not by blood stem cells, but rather their less pluripotent descendants, called progenitor cells.

6 Oct 2014

Scientists shed new light on how LAMR1 and Gal-3 proteins can cause meningitis, septicaemia

Previously undiscovered secrets of how human cells interact with a bacterium which causes a serious human disease have been revealed in new research by microbiologists at The University of Nottingham.

5 Oct 2014

Vitamin D supplement significantly reduces symptoms of winter-related atopic dermatitis

A study conducted in more than 100 Mongolian schoolchildren found that daily treatment with a vitamin D supplement significantly reduced the symptoms of winter-related atopic dermatitis, a type of eczema.

5 Oct 2014

CTRC researcher receives special $1.62 million orphan disease grant from FDA

A researcher at the Cancer Therapy & Research Center is the leader on a study receiving a special $1.62 million orphan disease grant from the Food & Drug Administration.

5 Oct 2014

Kessler Foundation, NJHF partner to advance biomedical research

The signing of a formal affiliation agreement that allows Kessler Foundation and New Jersey Health Foundation to work together to advance biomedical research, education and patient care programs has been announced by Rodger DeRose, president and chief executive officer of Kessler Foundation and James M. Golubieski, president of New Jersey Health Foundation.

5 Oct 2014

Bankers Healthcare Group going pink for national breast cancer awareness month

Bankers Healthcare Group, Inc., a leading provider of innovative financing solutions for healthcare professionals, is going pink this October for national breast cancer awareness month.

5 Oct 2014

Aflac announces new campaign to support National Breast Cancer Awareness Month

Aflac, the leading provider of voluntary insurance in the United States, announced a new campaign aimed at helping stamp out breast cancer during National Breast Cancer Awareness Month, with net proceeds going to the American Association for Cancer Research Foundation.

3 Oct 2014

Halozyme's PEGPH20 receives FDA Orphan Drug designation for treatment of pancreatic cancer

Halozyme Therapeutics, Inc. today announced that the U.S. Food and Drug Administration has granted Orphan Drug designation for PEGylated recombinant human hyaluronidase (PEGPH20) for the treatment of pancreatic cancer.

3 Oct 2014

TyrRS enzyme protects DNA during cellular stress

Scientists at The Scripps Research Institute have found that an enzyme best known for its fundamental role in building proteins has a second major function: to protect DNA during times of cellular stress.

3 Oct 2014

LA BioMed researchers report that THC may help protect the brain of traumatic brain injury patients

Surveying patients with traumatic brain injuries, a group of Los Angeles Biomedical Research Institute researchers reported today that they found those who tested positive for THC, the active ingredient in marijuana, were more likely to survive than those who tested negative for the illicit substance.

3 Oct 2014

Diet may influence susceptibility to autoinflammatory bone disease in at-risk individuals

Diet-induced changes in the gut's bacterial ecosystem can alter susceptibility to an autoinflammatory bone disease by modifying the immune response, St. Jude Children's Research Hospital scientists reported. The findings appeared September 28 as an advanced online publication of the scientific journal Nature.

3 Oct 2014

IRCM researchers discover mechanism that promotes progression of medulloblastoma

Scientists at the IRCM discovered a mechanism that promotes the progression of medulloblastoma, the most common brain tumour found in children. The team, led by Fr-d-ric Charron, PhD, found that a protein known as Sonic Hedgehog induces DNA damage, which causes the cancer to develop.

3 Oct 2014

Study: Abortion restrictions lead to poorer health

The study, however, was paid for by groups that support abortion rights. Elsewhere, California's Catholic Church leadership files a civil-rights complaint over making insurance plans cover abortion.

3 Oct 2014

Women can now take proactive steps to reduce breast cancer risk

Now that medical professionals have identified gene mutations that predispose for breast cancer, patients can take proactive steps to reduce their risk.

3 Oct 2014

ERK and JNK enzymes may offer solutions for treating endometrial, colon cancers

In the quest to solve cancer's mysteries, they come in handy when describing tongue-twisting processes and pathways that somehow allow tumors to form and thrive. Two examples are ERK (extracellular-signal-related kinase) and JNK (c-June N-Terminal Kinase), enzymes that may offer unexpected solutions for treating some endometrial and colon cancers.

3 Oct 2014

Exclusive partnership brings together next-generation proteomics and next-generation sequencing

AB SCIEX and Illumina (NASDAQ: ILMN) announced today the OneOmics™ project, an exclusive partnership to bring together SWATH™-based next-generation proteomics (NGP) and next-generation sequencing (NGS) tools in a cloud computing environment.

3 Oct 2014

Researchers analyze incidence of childhood brain tumors

Older parents, birth defects, maternal nutrition and childhood exposure to CT scans and pesticides are increasingly being associated with brain tumors in children, according to new research from the Brown School at Washington University in St. Louis.

3 Oct 2014

Genoscience Pharma to present novel cancer therapeutic strategy at EORTC-NCI-AACR Symposium

Genoscience Pharma, a company focused on discovering and developing small molecules to treat cancer by targeting cancer stem cells, today announces that it will present data on its most promising candidate at the 26th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics, in Barcelona, Spain, on November 18-21, 2014.

3 Oct 2014

Cancer News and Research

Latest Cancer News and Research

Scientists identify genetic factors that influence height in individuals

SynGen announces securement of additional financing from San Francisco-based life sciences venture capital firm

New research on barcoding tool that tracks origin of blood cells challenges scientific dogma

Scientists shed new light on how LAMR1 and Gal-3 proteins can cause meningitis, septicaemia

Vitamin D supplement significantly reduces symptoms of winter-related atopic dermatitis

CTRC researcher receives special $1.62 million orphan disease grant from FDA

Kessler Foundation, NJHF partner to advance biomedical research

Bankers Healthcare Group going pink for national breast cancer awareness month

Aflac announces new campaign to support National Breast Cancer Awareness Month

Halozyme's PEGPH20 receives FDA Orphan Drug designation for treatment of pancreatic cancer

TyrRS enzyme protects DNA during cellular stress

LA BioMed researchers report that THC may help protect the brain of traumatic brain injury patients

Diet may influence susceptibility to autoinflammatory bone disease in at-risk individuals

IRCM researchers discover mechanism that promotes progression of medulloblastoma

Study: Abortion restrictions lead to poorer health

Women can now take proactive steps to reduce breast cancer risk

ERK and JNK enzymes may offer solutions for treating endometrial, colon cancers

Exclusive partnership brings together next-generation proteomics and next-generation sequencing

Researchers analyze incidence of childhood brain tumors

Genoscience Pharma to present novel cancer therapeutic strategy at EORTC-NCI-AACR Symposium

Understanding the DNA Damage Response in Innate Immunity eBook

Directed enzyme evolution and the Nobel Prize: Making enzymes evolve in the lab

Advancing Motor Neuron Disease Diagnosis with Non-Invasive Ultrasound and AI

How agentic AI is reshaping laboratory workflows

Cancer News and Research

Latest Cancer News and Research

Understanding the DNA Damage Response in Innate Immunity eBook

Directed enzyme evolution and the Nobel Prize: Making enzymes evolve in the lab

Advancing Motor Neuron Disease Diagnosis with Non-Invasive Ultrasound and AI

How agentic AI is reshaping laboratory workflows

Newsletters you may be interested in